IO Biotech, Inc.IOBTNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank77
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P77
Within normal range
vs 2Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 6.78% |
| Q2 2025 | 14.08% |
| Q1 2025 | -17.56% |
| Q4 2024 | 5.69% |
| Q3 2024 | -22.53% |
| Q2 2024 | 31.89% |
| Q1 2024 | -9.37% |
| Q4 2023 | -42.56% |
| Q3 2023 | 12.44% |
| Q2 2023 | -24.32% |
| Q1 2023 | -17.28% |
| Q4 2022 | 6.16% |
| Q3 2022 | -2.59% |
| Q2 2022 | 37.58% |
| Q1 2022 | -8.34% |
| Q4 2021 | -135.47% |
| Q3 2021 | 13.08% |
| Q2 2021 | -141.55% |
| Q1 2021 | -25.79% |
| Q4 2020 | -43.11% |
| Q3 2020 | -91900.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |